Urology
Volume 8, Issue 5 , Pages 459-464 , November 1976

Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma

References 

  1. Carter SK, Wasserman TH. The chemotherapy of urologic cancer. Cancer. 1975;36:729
  2. Yagoda A. Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma. Cancer. 1973;32:1131
  3. Scott WW, et al. Comparison of 5-fluorouracil and cyclophosphamide in patients with advanced carcinoma of the prostate. Cancer Chemother. Rep. 1975;59:195
  4. Corbett TH, et al. Cyclophosphamide - Adriamycin combination chemotherapy of transplantable murine tumors. Cancer Res. 1975;35:1568
  5. Goldin A, Mantel N. The employment of combinations of drugs in the chemotherapy of neoplasia: a review. Cancer Res. 1957;17:635
  6. Kline I. Potentially useful combinations of chemotherapy detected in mouse tumor systems. Part 2 Cancer Chemother. Rep. (Suppl.). 1974;4:33
  7. Soloway MS. Single and combination chemotherapy for primary murine bladder cancer. Cancer. 1975;36:333
  8. Henderson ES, Samaha RJ. Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res. 1969;29:2272
  9. Salmon SE, Jones SE. Chemotherapy of advanced breast cancer with a combination of Adriamycin and cyclophosphamide. In: 2nd ed.. Proc. Am. Cancer Res. 15:1974;p. 90
  10. Weinstein SH, Schmidt JD. Adriamycin chemotherapy in advanced transitional cell carcinoma. In: Presented at North Central Section. AUA; October, 1975;
  11. Merrin C, et al. Chemotherapy of bladder carcinoma with Cytoxan and Adriamycin. J. Urol. 1975;114:884
  12. Whitmore, W. F., Jr.: Personal communication, January, 1976.
  13. Pavone-Macaluso M. Chemotherapy of vesical and prostatic tumors. Br. J. Urol. 1971;43:701
  14. Fox M. The effect of cyclophosphamide on some urinary tract tumors. Br. J. Urol. 1965;37:399
  15. Eagan RT, Utz DC, Myers RP, Furlow WL. Comparison of Adriamycin and the combination of 5-fluorouracil and cyclophosphamide in advanced prostatic cancer: a preliminary report. Cancer Chemother. Rep. 1975;59:203
  16. DeWys WD. Comparison of Adriamycin and 5 fluorouracil in advanced prostatic cancer. Cancer Chemother. Rep. 1975;59:215
  17. Slavik M., andCarter S.K.: Single agents in prostatic cancer - a quick review. Prepared for National Prostatic Cancer Project, National Cancer Institute, N.I.H., Bethesda, Maryland.
  18. Murphy GP. The chemotherapy of prostate cancer. In: Murphy GP, Mittelman A editor. Chemotherapy of Urogenital Tumors. Springfield: Charles C Thomas; 1975;p. 26–74
  19. Carter SK. The chemotherapy of bladder cancer. In: Murphy GP, Mittelman A editor. Chemotherapy of Urogenital Tumors. Springfield: Charles C Thomas; 1975;p. 105–127
  20. Stein JJ, Kaufman JJ. The treatment of carcinoma of the bladder with special reference to the use of preoperative radiation therapy combined with 5-fluorouracil. Am. J. Roentgenol. 1968;102:519
  21. Derek TL, Wilson WL. Use of 5-fluorouracil in treatment of bladder carcinomas. J. Urol. 1960;83:390
  22. Nevin JE, et al. The continuous arterial infusion of 5-fluorouracil as a therapeutic adjuvant in the treatment of advanced carcinoma of the bladder and prostate. Cancer. 1973;31:138
  23. Prout GR, Slack NH, Bross IDJ. Irradiation and 5-fluorouracil as adjuvants in the management of invasive bladder carcinoma. A cooperative group report after four years. J. Urol. 1970;104:116
  24. Prout GR, Bross IDJ, Slack NH, Ausman RK. Carcinoma of the bladder, 5-fluorouracil and the critical role of a placebo. Cancer. 1968;22:926
  25. Middleman E, Luce J, Frei E. Clinical trials with Adriamycin. Cancer. 1971;32:844
  26. O'Bryan RM, et al. Phase 11 evaluation of Adriamycin in human neoplasia. Cancer. 1973;32:1
  27. Soloway MS, deKernion JB, Rose D, Persky L. Effect of chemotherapeutic agents on bladder cancer. A new animal model. Surg. Forum. 1973;13:542
  28. DeKernion JB, Soloway MS, Persky L. Chemotherapy of experimental transitional cell carcinoma. Urology. 1974;4:63

 Presented at the Annual Meeting of the Southeastern Section of the American Urological Association, Inc., Hollywood, Florida, April, 1976.

PII: 0090-4295(76)90275-2

Urology
Volume 8, Issue 5 , Pages 459-464 , November 1976

Article Tools